GWAS and the depths of variation
Large genetic study brings Alzheimer's closer to early detection and new treatments
One of the largest genetic studies into Alzheimer's reveals that many more DNA variants contribute to the risk of the disease than was previously known. The results by statistical geneticist Emil Uffelmann offer new leads for drug development and could help identify people at increased risk years before the first symptoms appear in the future. This marks another important step in unraveling the genetic causes of Alzheimer's disease.
Read more in the news item
More information on the thesis